RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
  CTVS
  Plastic Surgery
  Transplantation
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
CTVS Channel

subscribe to CTVS newsletter
Latest Research : Surgery : CTVS

   EMAIL   |   PRINT
Heparin antibodies increase mortality in heart surgery patients

Dec 5, 2005 - 6:12:00 AM
"Researchers are at the cutting edge of learning about heparin antibodies and how they affect surgical outcomes. We need to understand more about mechanisms underlying the adverse effects of heparin antibodies and whether alternative anti-clotting medications will prove safer before informed recommendations can be made to patients and surgeons."

 
[RxPG] New research suggests that patients who develop antibodies to the anti-clotting drug heparin nearly double their risk of death or serious complication after heart surgery.

"Complications after heart surgery are typically attributed to the surgery alone," said Thomas Slaughter, M.D., co-principal investigator on the project and a professor of anesthesiology at Wake Forest University Baptist Medical Center. "Our study examined whether development of heparin antibodies before surgery poses an independent risk."

The study, which involved 466 patients scheduled to undergo either coronary artery bypass or valve replacement surgery, is reported in this month's Journal of Thoracic and Cardiovascular Surgery. Conducted by investigators at Wake Forest University Baptist and Duke University medical centers, it is the first study to convincingly demonstrate a relationship between heparin antibodies and complications after cardiac surgery.

Heparin is administered intravenously during many procedures, including kidney dialysis, heart catheterization or angioplasty, as well as during heart and vascular surgeries. Estimates suggest that nearly half of patients treated with heparin develop the antibodies, which may last for months.

The researchers theorize that in patients with heparin antibodies, subsequent treatment with heparin activates blood components that cause clotting and inflammation, increasing the risk for heart attacks, heart rhythm problems, strokes and other complications.

"While it is too early to recommend universal testing for the antibodies, our study is the most definitive evidence to date that heparin antibodies increase the risk for death and complications associated with cardiac surgery," said Slaughter.

The researchers tested heparin antibody levels in all study patients before surgery. They found that patients with the antibodies experienced a nearly twofold greater risk of death or hospitalization extending longer than 10 days. The researchers used an extended hospital stay as a surrogate marker for other complications after surgery such as heart attacks, strokes, infection and kidney problems.

To ensure that patients' baseline health status did not influence results, the researchers assessed each patient's predicted surgical risk using a standardized risk scoring system called the Parsonnet risk score. This system is based on 19 factors known to be associated with death or other complications after heart surgery. The researchers found that regardless of the Parsonnet score, patients with heparin antibodies before surgery fared worse than patients without the antibodies.

More than 350,000 adult cardiac surgeries are performed in the United States each year. In this study, as many as13 percent of surgical patients were found to have heparin antibodies before undergoing surgery.

Slaughter says there is no simple solution to the problem. Several anti-clotting medications may provide an alternative to heparin, but they are not approved by the Food and Drug Administration for use during heart surgery. The safety of these alternative medications in the setting of complex heart surgery remains to be determined.

Another option may be for patients with the antibodies to delay surgery until the antibody levels subside. However, in some cases this might require months – and, in many cases, the severity of a patient's disease may not allow for safe delay of surgery.

"Researchers are at the cutting edge of learning about heparin antibodies and how they affect surgical outcomes," said Slaughter. "We need to understand more about mechanisms underlying the adverse effects of heparin antibodies and whether alternative anti-clotting medications will prove safer before informed recommendations can be made to patients and surgeons."



Publication: Journal of Thoracic and Cardiovascular Surgery
On the web: www.wfubmc.edu 

Advertise in this space for $10 per month. Contact us today.


Related CTVS News
Clopidogrel does not increase postoperative bleeding risk in patients with Acute Coronary Syndrome
AAAs are best operated at large centres - study suggests
'Off-pump' CABG appears to have no benefit on cognitive or cardiac outcomes at 5 years
Minimally invasive approach and a revolutionary device to treat thoracic aortic aneurysm
Cox-maze IV: New simpler technique for persistent Atrial Fibrillation
Nesiritide may be beneficial in the prevention of renal dysfunction after CABG
Aprotinin use during CABG associated with increased mortality rates
Mayo Clinic surgeons propose a system of quality indicators for lung surgery
Off-pump CABG is a safer option
Off-pump CABG is a safer option

Subscribe to CTVS Newsletter

Enter your email address:


 Additional information about the news article
Other members of the research team included Elliott Bennett-Guerrero, M.D., William White, M.P.H., Ian J. Welsby, M.D., Charles Greenberg, M.D., Habib El-Moalem, Ph.D., and Thomas L. Ortel, M.D., Ph.D., all from Duke University Medical Center.

Wake Forest University Baptist Medical Center is an academic health system comprised of North Carolina Baptist Hospital and Wake Forest University Health Sciences, which operates the university's School of Medicine. The system comprises 1,187 acute care, psychiatric, rehabilitation and long-term care beds and is consistently ranked as one of "America's Best Hospitals" by U.S. News & World Report.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)